tiprankstipranks
Paradigm Biopharmaceuticals Ltd. (PBIGF)
OTHER OTC:PBIGF
US Market
PBIGF
Paradigm Biopharmaceuticals
RESEARCH TOOLSreports
Want to see PBIGF full AI Analyst Report?

Paradigm Biopharmaceuticals (PBIGF) Income Statement

17 Followers

Paradigm Biopharmaceuticals Income Statement

Last quarter (Q2 2026), Paradigm Biopharmaceuticals's total revenue was AU$25.15K, an increase of Infinity% from the same quarter last year. In Q2, Paradigm Biopharmaceuticals's net income was AU$-23.24M. See Paradigm Biopharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 52.12KAU$ 65.80KAU$ 46.76KAU$ 79.22KAU$ 20.55K
Gross Profit
AU$ -19.89KAU$ 56.81KAU$ -18.83KAU$ -64.53KAU$ -78.59K
Operating Expenses
AU$ 22.87MAU$ 65.10MAU$ 60.07MAU$ 47.93MAU$ 43.31M
Depreciation and Amortization
AU$ 51.42KAU$ 146.74KAU$ 153.66KAU$ 193.25KAU$ 210.06K
EBITDA
AU$ -25.25MAU$ -64.54MAU$ -59.06MAU$ -46.82MAU$ -42.40M
Operating Income
AU$ -22.89MAU$ -65.19MAU$ -59.22MAU$ -47.01MAU$ -42.34M
Other Income/Expenses
AU$ -2.42MAU$ 6.54MAU$ 263.61KAU$ -1.48KAU$ -302.21K
Pretax Income
AU$ -25.30MAU$ -58.65MAU$ -58.95MAU$ -47.01MAU$ -42.65M
Net Income
AU$ -18.77MAU$ -58.65MAU$ -51.91MAU$ -39.25MAU$ -34.30M
Per Share Metrics
Basic EPS
AU$ -0.06AU$ -0.20AU$ -0.18AU$ -0.16AU$ -0.16
Diluted EPS
AU$ -0.06AU$ -0.20AU$ -0.18AU$ -0.16AU$ -0.16
Weighted Average Shares Outstanding
 314.50M 293.28M 289.68M 240.96M 212.19M
Weighted Average Shares Outstanding (Diluted)
 314.50M 293.28M 289.68M 241.82M 212.19M
Currency in AUD

Paradigm Biopharmaceuticals Earnings and Revenue History